IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Caxton Corp

Q3 2017 Holdings

Filed 2017-11-14 | 16 holdings | $361.0K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Aclaris Therapeutics Inc(ACRS)COM00461U105$263.0K10,17672.9%
Strongbridge Biopharma PLCSHS USDG85347105$38.1K5,514,99410.5%
Spdr S&P 500 ETF TR(SPY)PutTR UNIT78462F103$19.4K77,0525.4%
Kala Pharmaceuticals IncCOM483119103$12.4K544,2203.4%
Agile Therapeutics Inc(AGRXUSD)COM00847L100$8.1K1,820,0122.2%
Garrison Cap Inc(GARSUSD)COM366554103$7.2K850,0002.0%
Molecular Templates IncCOM608550109$7.1K1,013,7872.0%
Berkshire Hathaway Inc del(BRK/B)CL B NEW084670702$1.6K8,9450.5%
JBG Smith Pptys(JBGS)COM46590V100$1.2K36,1290.3%
Intec Pharma LTD JerusalemSHSM53644106$68176,1390.2%
CM FIN IncCOM12574Q103$57461,4290.2%
GTX Inc delCOM NEW40052B207$53162,8690.1%
Adient PLC(ADNT)ORD SHSG0084W101$3984,7370.1%
Team Health Holdings IncCOM87817A107$3357,7090.1%
Jazz Pharmaceuticals PLC(JAZZ)SHS USDG50871105$3061,9970.1%
Marinus Pharmaceuticals IncCOM56854Q101$9516,1980.0%